Literature DB >> 9875878

The National Cholesterol Education Program: progress and prospects.

J I Cleeman1, C Lenfant.   

Abstract

The National Cholesterol Education Program (NCEP) is a prime example of the role the National Heart, Lung, and Blood Institute has played, in its 50 years of existence, as a catalyst for translating research advances into improved clinical and public health practices. Since its inception in 1985, the NCEP has adhered to 2 principles in mounting educational campaigns for professionals and the public: building on a strong science base and working in partnership with other organizations. In slightly more than a decade, the NCEP has made significant progress toward its goal of reducing the prevalence of high blood cholesterol. The impact of cholesterol education is clearly visible in 4 major trends: increasing professional and public cholesterol awareness; declining dietary intakes of saturated fat, total fat, and cholesterol; falling serum cholesterol levels; and a continuing decline in coronary heart disease (CHD) mortality rates. Nevertheless, cholesterol levels are still being undertreated, especially in patients with CHD, and substantial scientific and educational challenges remain. As it looks forward to the 21st century, the NCEP plans to make continued progress by using emerging scientific developments and pursuing the powerful combination of cholesterol lowering in CHD patients and in primary prevention.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875878     DOI: 10.1001/jama.280.24.2099

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

Review 1.  The increasing necessity for market-based pharmaceutical prices.

Authors:  J E Calfee
Journal:  Pharmacoeconomics       Date:  2000       Impact factor: 4.981

2.  Nutrition, environment and cardiovascular health (NESCAV): protocol of an inter-regional cross-sectional study.

Authors:  Ala'a Alkerwi; Michèle Guillaume; Faiez Zannad; Ulrich Laufs; Marie-Lise Lair
Journal:  BMC Public Health       Date:  2010-11-15       Impact factor: 3.295

3.  Body mass index as a predictor of hypertension incidence among initially healthy normotensive women.

Authors:  Sara L Shuger; Xuemei Sui; Timothy S Church; Rebecca A Meriwether; Steven N Blair
Journal:  Am J Hypertens       Date:  2008-04-10       Impact factor: 2.689

4.  Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies.

Authors:  Roberta E Goldman; Donna R Parker; Charles B Eaton; Jeffrey M Borkan; Robert Gramling; Rebecca T Cover; David K Ahern
Journal:  Ann Fam Med       Date:  2006 May-Jun       Impact factor: 5.166

5.  Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction.

Authors:  John Z Ayanian; Bruce E Landon; Mary Beth Landrum; James R Grana; Barbara J McNeil
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

6.  The impact of combined health factors on cardiovascular disease mortality.

Authors:  Jonathan A Mitchell; Daniel B Bornstein; Xuemei Sui; Steven P Hooker; Timothy S Church; Chong D Lee; Duck-Chul Lee; Steven N Blair
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

7.  Immigration disparities in cardiovascular disease risk factor awareness.

Authors:  Brent A Langellier; Jeremiah R Garza; Deborah Glik; Michael L Prelip; Ron Brookmeyer; Christian K Roberts; Anne Peters; Alexander N Ortega
Journal:  J Immigr Minor Health       Date:  2012-12

8.  Blood cholesterol screening influence of fasting state on cholesterol results and management decisions.

Authors:  S R Craig; R V Amin; D W Russell; N F Paradise
Journal:  J Gen Intern Med       Date:  2000-06       Impact factor: 5.128

9.  Halting the obesity epidemic: a public health policy approach.

Authors:  M Nestle; M F Jacobson
Journal:  Public Health Rep       Date:  2000 Jan-Feb       Impact factor: 2.792

10.  Health-related quality of life in cardiac patients with dyslipidemia and hypertension.

Authors:  Lyne Lalonde; Annette O'Connor; Lawrence Joseph; Steven A Grover
Journal:  Qual Life Res       Date:  2004-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.